Quinolin-7-ylmethanamine dihydrochloride

Catalog No.: 
ACHQRY469
CAS No.: 
2503203-31-2
Molecular Formula: 
C10H12Cl2N2
Molecular Weight: 
231.13
Quinolin-7-ylmethanamine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg97%
50mg97%
100mg97%
250mg97%
500mg97%
1g97%
5g97%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameQuinolin-7-ylmethanamine dihydrochloride
IUPAC Namequinolin-7-ylmethanamine dihydrochloride
MDL No.0
Molecular FormulaC10H12Cl2N2
Molecular Weight231.13
SMILESNCC1=CC=C2C=CC=NC2=C1.[H]Cl.[H]Cl
InChI KeyUSXVTPWOILIRAS-UHFFFAOYSA-N
Synonymquinolin-7-ylmethanamine dihydrochloride;7-quinolylmethanamine
CAS No.2503203-31-2
PubChem CID154814566

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACHQRY469 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACHQRY469 route product structure diagram
    ACHQRY4692503203-31-2In Stock
Inquiry

2. ACHQRY469 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPQMX715 route compound structure diagram
    ACPQMX71567360-38-7In Stock
  2. Then
  3. ACHQRY469 route product structure diagram
    ACHQRY4692503203-31-2In Stock
Inquiry

3. ACHQRY469 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHQRY469 route product structure diagram
    ACHQRY4692503203-31-2In Stock
Inquiry

Comments (0)